Skip to main content
Kim Tank

Featured Patient Story

Kim Tank

In July of 2013, I was diagnosed by a kidney biopsy. I had gone to the doctor with just one symptom of swollen ankles. I have AL Amyloidosis and we believe the only place I have it is in my kidneys. I work with a local oncologist in Pleasant Hill, CA, and he consults with the Amyloid team at Stanford. In August of 2013, I began treatment with CyBorD. After two months, the Cytoxan was replaced with Revlimid because the response with Cytoxan was not as fast as they would have liked. My bone marrow biopsy in April of 2014 still showed a higher than normal level of plasma cells, so we began discussing other options.

read more

Latest News Story Headlines

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Nov 25, 2024

− Prescription Drug User Fee Act (PDUFA) Date Set for March 23, 2025 −

read full article
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

11.22.2024 at 7:12 PM EST

read full article
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis

CAMBRIDGE, Mass., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc.

read full article

Calendar & Upcoming Events

Webinar: Amyloidosis and Anxiety

 Webinar Session, Wednesday, Jan. 15th, 2025 at 6 PM (ET)  Zoom Meeting

view all event details

Nashville Support Group Meeting

When: February 1st, 2025 1:00 am CT

view all event details

Amyloidosis Videos

Our Latest Webinar

Updates in AL amyloidosis: Fast Forward in 2024!

Heather Landau, MD - Memorial Sloan Kettering Cancer Center - New York, NY

Sign Up for the Latest Updates

Get news from Amyloidosis Foundation
in your inbox

By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.